Akebia Therapeutics Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

2.40

-0.01 (-0.41%)

At close: May 01, 2025, 3:59 PM

2.40

0.18%

After-hours: May 01, 2025, 07:59 PM EDT

Akebia Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-69.41M	-51.92M	-92.56M	-282.84M	-383.46M	-279.66M	-143.59M	-76.91M	-135.75M
Depreciation & Amortization	37.5M	41.85M	37.7M	37.97M	33.59M	38.65M	2.42M	617K	296K
Stock-Based Compensation	7.78M	9.32M	17.85M	22.73M	24.46M	11.93M	19.04M	8.87M	5.83M
Other Working Capital	-13.96M	-13.94M	-34.42M	-46.81M	-35.52M	-49.1M	-11.11M	-14.11M	187.01M
Other Non-Cash Items	-16.53M	-1.9M	-34.7M	41.01M	24.61M	77.35M	16.95M	4.02M	800K
Deferred Income Tax	n/a	n/a	n/a	36.58M	204.08M	-6.63M	-28.34M	n/a	n/a
Change in Working Capital	n/a	-20.73M	-1.44M	-108.42M	-13.67M	-99.07M	36.02M	7.25M	186.73M
Operating Cash Flow	-40.66M	-23.38M	-73.15M	-252.97M	-110.39M	-257.44M	-97.49M	-56.16M	57.91M
Capital Expenditures	-33K	n/a	-114K	-59K	-317K	-6.66M	-1.61M	-1.62M	-2.66M
Cash Acquisitions	n/a	n/a	n/a	n/a	39.69M	n/a	6.15M	1.62M	2.66M
Purchase of Investments	n/a	n/a	n/a	n/a	-99.93M	n/a	-224.22M	-330.64M	-147.01M
Sales Maturities Of Investments	n/a	n/a	n/a	40M	60.24M	217.83M	256.27M	155M	162.38M
Other Investing Acitivies	n/a	n/a	n/a	40M	-39.69M	217.83M	32.05M	-1.62M	-2.66M
Investing Cash Flow	-33K	n/a	-114K	39.94M	-40M	211.18M	36.59M	-177.26M	12.71M
Debt Repayment	7.9M	-32M	-33M	n/a	19.98M	62.67M	-19K	-5K	-20K
Common Stock Repurchased	-1.27M	n/a	n/a	n/a	n/a	-426K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	385K	1K	40.07M	133.73M	1.23M	560K	647K	1.31M	124K
Financial Cash Flow	49.66M	-25.21M	14.6M	133.73M	231.72M	88.97M	96.56M	116.24M	66.95M
Net Cash Flow	8.97M	-48.59M	-58.67M	-79.29M	81.33M	42.7M	35.66M	-117.18M	137.56M
Free Cash Flow	-40.69M	-23.38M	-73.27M	-253.02M	-110.7M	-264.1M	-99.1M	-57.78M	55.24M